The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ctDNA kinetics throughout first-line AI and palbociclib using a tumor-informed structural variant-based ctDNA assay: Retrospective analysis of PADA-1 samples.
 
Luc Cabel
No Relationships to Disclose
 
Veronique D'hondt
Travel, Accommodations, Expenses - Accord Healthcare; AstraZeneca; GlaxoSmithKline; Lilly; Novartis; Pfizer
 
Thomas Bachelot
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; pfizer; Roche
 
Patrick Soulie
Travel, Accommodations, Expenses - Ipsen; Pfizer; PharmaMar
 
Chantal Bernard-Marty
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer
 
Pascal Boucher
No Relationships to Disclose
 
Clara Guyonneau
No Relationships to Disclose
 
Anne Pradines
No Relationships to Disclose
 
Völundur Hafstad
Employment - SAGA Diagnostics
 
Celine Callens
No Relationships to Disclose
 
Sofia Birkealv
Employment - SAGA Dx
Stock and Other Ownership Interests - AstraZeneca; SAGA Dx
Patents, Royalties, Other Intellectual Property - Patent - SAGA Dx
 
Miguel Alcaide Torres
Employment - SAGA Dx
Stock and Other Ownership Interests - SAGA Dx
Patents, Royalties, Other Intellectual Property - Methods for ctDNA monitoring
Travel, Accommodations, Expenses - SAGA Dx
 
Jennifer Yen
Employment - Exai Bio; SAGA Diagnostics
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health - cfDNA analyses; Guardant Health - cfDNA analyses
Travel, Accommodations, Expenses - Exai Bio; SAGA Diagnostics; SAGA Diagnostics; SAGA Diagnostics
 
Karen Howarth
Employment - NeoGenomics Laboratories; SAGA Diagnostics
Stock and Other Ownership Interests - NeoGenomics Laboratories; SAGA Diagnostics
 
Frederique Berger
No Relationships to Disclose
 
Francois Clement Bidard
Consulting or Advisory Role - AstraZeneca; Carrick Pharm; Daiichi-Sankyo; Hengrui Pharmaceutical ; Inatherys; Lilly; Menarini Silicon Biosystems; Novartis; Pfizer; Relay Tx; Roche; Tempus
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Roche
Research Funding - GE Healthcare (Inst); Menarini Silicon Biosystems (Inst); Merck KGaA (Inst); MSD (Inst); Natera (Inst); Novartis (Inst); Personalis (Inst); Pfizer (Inst); Prolynx (Inst); Roche (Inst); SAGA Dx (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - ESR1 & MSI detection techniques (patents) (Inst); Prognosis assessment by a digital pathology assay in early breast cancer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi-Sankyo; Novartis; Pfizer; Roche